4.6 Article

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

Journal

MOVEMENT DISORDERS
Volume 31, Issue 1, Pages 95-102

Publisher

WILEY-BLACKWELL
DOI: 10.1002/mds.26359

Keywords

cognition; GBA; neuropsychological tests; visuospatial; working memory

Funding

  1. National Institutes of Health [K23 NS060949, P01 AG017586, P01 ES016732, P30 AG010124, P50 AG005136, P50 NS038367, P50 NS038377, P50 NS053488, P50 NS062684, R01 ES010544, R01 NS065070, U01 NS082133, U54 ES012078]
  2. Department of Veterans Affairs [1I01BX000531]
  3. Consolidated Anti-Aging Foundation
  4. Dolsen Foundation
  5. Jane and Lee Seidman Fund
  6. Nancy and Buster Alvord Endowment
  7. Parkinson's Disease Foundation
  8. Sartain Lanier Family Foundation
  9. Office of Research and Development Medical Research Service, Department of Veterans Affairs
  10. National Center for Complementary & Integrative Health [U01AT000613] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012078, R01ES010544, P01ES016732] Funding Source: NIH RePORTER
  12. NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092735] Funding Source: NIH RePORTER
  13. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038367, U01NS082133, P50NS053488, U01NS052592, R01NS067525, U01NS082134, R01NS065070, K23NS060949, P50NS038377, P50NS062684, R37NS067525] Funding Source: NIH RePORTER
  14. NATIONAL INSTITUTE ON AGING [P50AG005136, U19AG024904, P30AG010124, P01AG017586, U01AG029213, P50AG005146, U01AG024904] Funding Source: NIH RePORTER
  15. NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER
  16. Veterans Affairs [I01BX000531] Funding Source: NIH RePORTER

Ask authors/readers for more resources

BackgroundLoss-of-function mutations in the GBA gene are associated with more severe cognitive impairment in PD, but the nature of these deficits is not well understood and whether common GBA polymorphisms influence cognitive performance in PD is not yet known. MethodsWe screened the GBA coding region for mutations and the E326K polymorphism in 1,369 PD patients enrolled at eight sites from the PD Cognitive Genetics Consortium. Participants underwent assessments of learning and memory (Hopkins Verbal Learning Test-Revised), working memory/executive function (Letter-Number Sequencing Test and Trail Making Test A and B), language processing (semantic and phonemic verbal fluency), visuospatial abilities (Benton Judgment of Line Orientation), and global cognitive function (MoCA). We used linear regression to test for association between genotype and cognitive performance with adjustment for important covariates and accounted for multiple testing using Bonferroni's corrections. ResultsMutation carriers (n=60; 4.4%) and E326K carriers (n=65; 4.7%) had a higher prevalence of dementia (mutations, odds ratio=5.1; P=9.7x10(-6); E326K, odds ratio=6.4; P=5.7x10(-7)) and lower performance on Letter-Number Sequencing (mutations, corrected P[P-c]=9.0x10(-4); E326K, P-c=0.036), Trail Making B-A (mutations, P-c=0.018; E326K, P-c=0.018), and Benton Judgment of Line Orientation (mutations, P-c=0.0045; E326K, P-c=0.0013). ConclusionsBoth GBA mutations and E326K are associated with a distinct cognitive profile characterized by greater impairment in working memory/executive function and visuospatial abilities in PD patients. The discovery that E326K negatively impacts cognitive performance approximately doubles the proportion of PD patients we now recognize are at risk for more severe GBA-related cognitive deficits. (c) 2015 International Parkinson and Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available